iResearch Atlanta

Atlanta, Georgia 30030

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease, Cognitive Decline, Cognitive Dysfunction, Dementia, Alzheimer Type, Mild Cognitive Impairment, Mild Dementia

Studies at this site

• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling
• Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type — Completed